KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$0.5.

  • Twist Bioscience's EPS (Basic) rose 566.04% to -$0.5 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.27, marking a year-over-year increase of 6242.6%. This contributed to the annual value of -$1.3 for FY2025, which is 6392.62% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's EPS (Basic) is -$0.5, which was up 566.04% from -$0.45 recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's EPS (Basic) peaked at $0.34 during Q2 2025, and registered a low of -$1.47 during Q2 2024.
  • Its 5-year average for EPS (Basic) is -$0.77, with a median of -$0.8 in 2023.
  • As far as peak fluctuations go, Twist Bioscience's EPS (Basic) tumbled by 7291.67% in 2021, and later soared by 12312.93% in 2025.
  • Over the past 5 years, Twist Bioscience's EPS (Basic) (Quarter) stood at -$0.91 in 2021, then increased by 18.68% to -$0.74 in 2022, then dropped by 1.35% to -$0.75 in 2023, then grew by 29.33% to -$0.53 in 2024, then rose by 5.66% to -$0.5 in 2025.
  • Its EPS (Basic) stands at -$0.5 for Q4 2025, versus -$0.45 for Q3 2025 and $0.34 for Q2 2025.